The pharmaceutical industry in Malaysia has grown steadily over the last decade and has been identified as a key growth area. Pharmaceutical products manufactured in Malaysia include new drug products, biologics, generics (prescription and over-the-counter (OTC) products), health and food supplements, traditional and complementary medicines (TCM) and veterinary products.
Local pharmaceutical manufacturers have the capabilities to produce most forms of dosage, including sterile preparations, injections and soft gelatine capsules. Many Malaysian manufacturers are carrying out contract manufacturing for MNCs.
Traditional and Complementary Medicine
Oncogen Pharma has set-up the first Oncology API R&D Centre in the ASEAN region. Oncogen has also completed its Formulation Research and Development Centre in the Hicom Glenmarie Industrial Park, Selangor and established its manufacturing facility in Techpark@Enstek, Negeri Sembilan. Malaysia was selected among many other countries due to its strategic importance in the region, ease of operations, quality of infrastructure and a talented pool of upcoming young scientists.